These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6026748)

  • 1. Duration of immunity to tuberculosis in mice vaccinated intravenously with oil-treated cell walls of Mycobacterium bovis strain BCG.
    Anacker RL; Barclay WR; Brehmer W; Larson CL; Ribi E
    J Immunol; 1967 Jun; 98(6):1265-73. PubMed ID: 6026748
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunity against Mycobacterium, with special reference to the experiments using BCG cell wall].
    Yamamoto K
    Kekkaku; 1976 May; 51(5):155-7. PubMed ID: 819704
    [No Abstract]   [Full Text] [Related]  

  • 3. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
    Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
    J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemical structures and biological functions of mycobacterial cell walls with special reference to immunity against airborne infection by the strain M. tuberculosis H37Rv].
    Ribi E; Azuma I; Meyer T; Parker R; Brehmer W; Yamamura Y
    Bull Int Union Tuberc; 1974; 49(1):366-77. PubMed ID: 4219732
    [No Abstract]   [Full Text] [Related]  

  • 5. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of remaining live BCG organisms in vaccinated mice on the maintenance of immunity to tuberculosis.
    Olsen AW; Brandt L; Agger EM; van Pinxteren LA; Andersen P
    Scand J Immunol; 2004 Sep; 60(3):273-7. PubMed ID: 15320884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antituberculous immunity, with special reference to protection against tuberculosis in mice immunized with cell walls from BCG (author's transl)].
    Yamamoto K
    Kekkaku; 1976 Nov; 51(11):453-62. PubMed ID: 1011437
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
    Mollenkopf HJ; Kursar M; Kaufmann SH
    J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
    Sun R; Skeiky YA; Izzo A; Dheenadhayalan V; Imam Z; Penn E; Stagliano K; Haddock S; Mueller S; Fulkerson J; Scanga C; Grover A; Derrick SC; Morris S; Hone DM; Horwitz MA; Kaufmann SH; Sadoff JC
    Vaccine; 2009 Jul; 27(33):4412-23. PubMed ID: 19500523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of pulmonary granuloma formation in mice by treatment with Mycobacterial protoplasm and immuno-suppressants and its relation to protection against aerosol infection with virulent Mycobacterium tuberculosis.
    Yamamoto K; Granger DL; Brehmer W; Azuma I; Ribi E
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981; 250(1-2):127-41. PubMed ID: 6797153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs.
    Martin C; Williams A; Hernandez-Pando R; Cardona PJ; Gormley E; Bordat Y; Soto CY; Clark SO; Hatch GJ; Aguilar D; Ausina V; Gicquel B
    Vaccine; 2006 Apr; 24(17):3408-19. PubMed ID: 16564606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.
    Brodin P; Majlessi L; Brosch R; Smith D; Bancroft G; Clark S; Williams A; Leclerc C; Cole ST
    J Infect Dis; 2004 Jul; 190(1):115-22. PubMed ID: 15195250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis.
    Aldwell FE; Cross ML; Fitzpatrick CE; Lambeth MR; de Lisle GW; Buddle BM
    Vaccine; 2006 Mar; 24(12):2071-8. PubMed ID: 16332403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
    Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A polyvalent DNA vaccine expressing an ESAT6-Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis and boosts BCG-induced protective immunity.
    Derrick SC; Yang AL; Morris SL
    Vaccine; 2004 Dec; 23(6):780-8. PubMed ID: 15542202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of oil-treated mycobacterial cell walls on the organs of mice.
    Barclay WR; Anacker R; Brehmer W; Ribi E
    J Bacteriol; 1967 Nov; 94(5):1736-45. PubMed ID: 4965197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice.
    Luo Y; Wang B; Hu L; Yu H; Da Z; Jiang W; Song N; Qie Y; Wang H; Tang Z; Xian Q; Zhang Y; Zhu B
    Vaccine; 2009 Oct; 27(44):6179-85. PubMed ID: 19712772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and protection induced by Mycobacterium tuberculosis mce-2 and mce-3 mutants in a Balb/c mouse model of progressive pulmonary tuberculosis.
    Aguilar LD; Infante E; Bianco MV; Cataldi A; Bigi F; Pando RH
    Vaccine; 2006 Mar; 24(13):2333-42. PubMed ID: 16388878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superiority of intravenously administered BCG and BCG cell walls in protecting rhesus monkeys (Macaca mulatta) against airborne tuberculosis.
    Anacker RL; Brehmer W; Barclay WR; Leif WR; Ribi E; Simmons JH; Smith AW
    Z Immunitatsforsch Exp Klin Immunol; 1972 May; 143(4):363-76. PubMed ID: 4282920
    [No Abstract]   [Full Text] [Related]  

  • 20. Cell-mediated immune responses in children towards secreted proteins of Mycobacterium bovis BCG.
    Surekha Rani H; Vijaya Lakshmi V; Sumanlatha G; Murthy KJ
    Tuberculosis (Edinb); 2005; 85(1-2):89-93. PubMed ID: 15687032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.